|
EmulsiFlex Top
Hundreds of EmulsiFlex units are in use world-wide. It is AVESTIN's
policy to keep customer's names and applications strictly confidential; each
individual user must be contacted for permission before we will disclose
detailed information. Here is a selected list of users, by company and
location:
|
1. GSK Pharmaceuticals, Belgium,
UK, USA
|
|
2. Aventis,
France, Germany, USA
|
|
3. Philipps-Universitaet Marburg, Germany
|
|
4. Max-Planck-Institut, Germany
|
|
5. NOVARTIS, Germany, Switzerland, USA, Italy
|
|
6. Bayer, Germany
|
|
7. Hikma Pharmaceuticals, Jordan
|
|
8. Gilead, CA, USA
|
|
9. Korea Institute of Bioscience
and Biotechnology, Taejeon,
Korea
|
|
10. Astra Zeneca, Sweden, UK,
USA
|
|
11. ETH-Zurich, Switzerland
|
|
12. Roche Inc., Switzerland, UK, USA
|
|
13. China Petroleum Corporation,
Taiwan
|
|
14. Taiwan Tung Yang Chemical
Industry Co. Ltd., Taipei,
Taiwan
|
|
15. Pfizer Inc.,
UK, USA
|
|
16. Baxter Healthcare,
USA
|
|
17. Alkermes Inc., Cambridge,
MA, USA
|
|
18. Scripps Research Institute, CA, USA
|
|
19. Merck & Company, USA
|
|
20. Johnston & Johnston, PA, USA
|
|
21. Memorial Sloan Kettering
Cancer Center, New York, USA
|
|
22. Boehringer-Ingelheim, CT, USA
|
|
23. Montpellier University, France
|
|
24. Salk Institute, CA, USA
|
|
25. Nanjing Sike Pharmaceuticals, China
|
|
26. Troikaa Pharmaceuticals, India
|
|
27. Althea, CA, USA
|
|
28. Ben Venue, OH, USA
|
|
29. Proel, Greece
|
|
30. JBF, Korea
|
|